News

The agreement resolved pending patent litigation involving GLUMETZA (extended release metformin tablets) 1000mg and 500mg. According to the agreement, Lupin gains right to sell a generic version of

The CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of Patients with Relapsed Multiple MyEloma (ASPIRE) trial enrolled 780 patients at approximately 200 sites. The

The grant will fund medicinal chemistry for proprietary compounds that interact with NMUR2 AND Omeros will retain ownership of any compound developed with the assistance of this NIDA

The collaboration will analyse the response of a targeted therapy in different cancer types and stratify patients to provide a more individualized cancer treatment with Apceth’s cell and

The additional capacity is expected to increase global supply of VPRIV and provides additional manufacturing flexibility. According to the company, the approval is also a critical first step

Potential adverse events after intravenous administration of solutions containing particulates may include disruption of blood flow within small blood vessels in the lung, localized inflammation and granuloma formation,

The solutions will be hosted from the Siemens Healthcare Cloud Computing Center (HCCC), in Malvern, Pennsylvania, US. In a strategic alliance with Dell, Siemens will deliver a cloud-based

The EHR system will connect all patient and client data throughout Concentra’s employer worksite locations. Concentra indends to use the Allscripts Clinical Quality Solution (CQS) to provide its

As per the agreement, Boehringer will provide all manufacturing and product supply from preclinical through Phase 1 development. Xencor is responsible for preclinical and clinical studies and retains